Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow

Objective. To assess efficacy and safety of nimulid and CONDROnova according to data of District rheumatologists of Moscow Material and methods. 216 adult outpatients (115 with osteoarthritis, 39 with rheumatoid arthritis, 22 with ankylosing spondylitis, 12 with gout, 8 with reactive arthritis, 2 wi...

Full description

Saved in:
Bibliographic Details
Main Authors: K M Kogan, G D Zolotareva, L L Bernstein, V A Gunchikova, T V Dovbysh, N I Kalyuzhnaya, G A Kirsanova, T S Kuneva, K A Lyutkina, I A Nikitina, B. K. Romanov, T N Spiridonova, N V Timonichev, G P Chemysh, T S Kochmareva
Format: Article
Language:Russian
Published: IMA PRESS LLC 2005-08-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/757
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399949882556416
author K M Kogan
G D Zolotareva
L L Bernstein
V A Gunchikova
T V Dovbysh
N I Kalyuzhnaya
G A Kirsanova
T S Kuneva
K A Lyutkina
I A Nikitina
B. K. Romanov
T N Spiridonova
N V Timonichev
G P Chemysh
T S Kochmareva
author_facet K M Kogan
G D Zolotareva
L L Bernstein
V A Gunchikova
T V Dovbysh
N I Kalyuzhnaya
G A Kirsanova
T S Kuneva
K A Lyutkina
I A Nikitina
B. K. Romanov
T N Spiridonova
N V Timonichev
G P Chemysh
T S Kochmareva
author_sort K M Kogan
collection DOAJ
description Objective. To assess efficacy and safety of nimulid and CONDROnova according to data of District rheumatologists of Moscow Material and methods. 216 adult outpatients (115 with osteoarthritis, 39 with rheumatoid arthritis, 22 with ankylosing spondylitis, 12 with gout, 8 with reactive arthritis, 2 with psoriatic arthritis and 18 with mixed pathology) were included. Nimulid (nimesulid) 200-300 mg/day and CONDROnova (250 mg of glucosamin sulfate and 200 mg of chondroitin sulfate) 2-6 capsules/day were administered as monotherapy or in combination. Quantitative assessment of clinical and laboratory parameters at different stages of therapy was performed. Frequency and spectrum of adverse events in pts with concomitant diseases were analyzed. Results. Nimulid provided fast analgetic and anti-inflammatory effect, Condronova - analgetic effect (with aftereffect). Effect of combination therapy was more rapid. Adverse events frequency in pts with concomitant diseases receiving nimulid and CONDROnova in abovementioned doses was low. Conclusion. Isolated and combined administration of nimulid and CONDROnova in pts with rheumatic diseases is highly effective and safe.
format Article
id doaj-art-e422f0a42ee44c4080a5d04ecc67f44e
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2005-08-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-e422f0a42ee44c4080a5d04ecc67f44e2025-08-20T03:38:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922005-08-01434586110.14412/1995-4484-2005-619697Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of MoscowK M KoganG D ZolotarevaL L BernsteinV A GunchikovaT V DovbyshN I KalyuzhnayaG A KirsanovaT S KunevaK A LyutkinaI A NikitinaB. K. RomanovT N SpiridonovaN V TimonichevG P ChemyshT S KochmarevaObjective. To assess efficacy and safety of nimulid and CONDROnova according to data of District rheumatologists of Moscow Material and methods. 216 adult outpatients (115 with osteoarthritis, 39 with rheumatoid arthritis, 22 with ankylosing spondylitis, 12 with gout, 8 with reactive arthritis, 2 with psoriatic arthritis and 18 with mixed pathology) were included. Nimulid (nimesulid) 200-300 mg/day and CONDROnova (250 mg of glucosamin sulfate and 200 mg of chondroitin sulfate) 2-6 capsules/day were administered as monotherapy or in combination. Quantitative assessment of clinical and laboratory parameters at different stages of therapy was performed. Frequency and spectrum of adverse events in pts with concomitant diseases were analyzed. Results. Nimulid provided fast analgetic and anti-inflammatory effect, Condronova - analgetic effect (with aftereffect). Effect of combination therapy was more rapid. Adverse events frequency in pts with concomitant diseases receiving nimulid and CONDROnova in abovementioned doses was low. Conclusion. Isolated and combined administration of nimulid and CONDROnova in pts with rheumatic diseases is highly effective and safe.https://rsp.mediar-press.net/rsp/article/view/757condronova®combination therapyosteoarthritisrheumatoid arthritisnimulid
spellingShingle K M Kogan
G D Zolotareva
L L Bernstein
V A Gunchikova
T V Dovbysh
N I Kalyuzhnaya
G A Kirsanova
T S Kuneva
K A Lyutkina
I A Nikitina
B. K. Romanov
T N Spiridonova
N V Timonichev
G P Chemysh
T S Kochmareva
Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
Научно-практическая ревматология
condronova®
combination therapy
osteoarthritis
rheumatoid arthritis
nimulid
title Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
title_full Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
title_fullStr Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
title_full_unstemmed Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
title_short Practical expirience of nimulid and CONDROnova® administration by District specialists and rheumatologists of Moscow
title_sort practical expirience of nimulid and condronova r administration by district specialists and rheumatologists of moscow
topic condronova®
combination therapy
osteoarthritis
rheumatoid arthritis
nimulid
url https://rsp.mediar-press.net/rsp/article/view/757
work_keys_str_mv AT kmkogan practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT gdzolotareva practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT llbernstein practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT vagunchikova practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT tvdovbysh practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT nikalyuzhnaya practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT gakirsanova practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT tskuneva practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT kalyutkina practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT ianikitina practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT bkromanov practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT tnspiridonova practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT nvtimonichev practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT gpchemysh practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow
AT tskochmareva practicalexpirienceofnimulidandcondronovaadministrationbydistrictspecialistsandrheumatologistsofmoscow